Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Name: Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma
License: Public Domain

Immunocore Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

malignant melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 454022
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.